ED vs INMB · P/E 18, rev $15.26B vs rev $14.0K
Consolidated Edison Inc (ED) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported INMB revenue for 2024-12-31 was $14.0K. Net income was -$42.1M. Revenue was down 91.0% from 2023-12-31 to 2024-12-31. INMB currently screens at market cap $33.5M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. INMB currently screens at market cap $33.5M.
Not investment advice. Open the ED and INMB stock pages for the full models.
Not investment advice.